{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T01:50:19Z","timestamp":1788313819058,"version":"build-2803163510"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,7,1]]},"DOI":"10.1093\/cvr\/cvt105","type":"journal-article","created":{"date-parts":[[2013,5,2]],"date-time":"2013-05-02T01:43:51Z","timestamp":1367459031000},"page":"35-43","source":"Crossref","is-referenced-by-count":89,"title":["Pathophysiological roles of nuclear factor kappaB (NF-kB) in pulmonary arterial hypertension: effects of synthetic selective NF-kB inhibitor IMD-0354"],"prefix":"10.1093","volume":"99","author":[{"given":"Susumu","family":"Hosokawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Go","family":"Haraguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihito","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokuni","family":"Arai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susumu","family":"Muto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Itai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shozaburo","family":"Doi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuki","family":"Mizutani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuaki","family":"Isobe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,4,30]]},"reference":[{"key":"key\n\t\t\t\t20170523020623_CVT105C1","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMra040291","article-title":"Treatment of pulmonary arterial hypertension","volume":"351","author":"Humbert","year":"2004","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170523020623_CVT105C2","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1161\/HYPERTENSIONAHA.109.133397","article-title":"Resveratrol prevents monocrotaline-induced pulmonary hypertension in rats","volume":"54","author":"Csiszar","year":"2009","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t20170523020623_CVT105C3","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1093\/eurheartj\/ehp297","article-title":"Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)","volume":"30","author":"Galie","year":"2009","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20170523020623_CVT105C4","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1093\/eurheartj\/ehq152","article-title":"Pulmonary arterial hypertension: from the kingdom of the near-dead to multiple clinical trial meta-analyses","volume":"31","author":"Galie","year":"2010","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20170523020623_CVT105C5","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1161\/01.RES.0000243584.45145.3f","article-title":"Hypoxia-induced pulmonary vascular remodeling\u2014cellular and molecular mechanisms","volume":"99","author":"Stenmark","year":"2006","journal-title":"Circ Res"},{"key":"key\n\t\t\t\t20170523020623_CVT105C6","first-page":"275","article-title":"Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension","volume":"144","author":"Tuder","year":"1994","journal-title":"Am J Pathol"},{"key":"key\n\t\t\t\t20170523020623_CVT105C7","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1183\/09031936.03.00038903","article-title":"Inflammation in pulmonary arterial hypertension","volume":"22","author":"Dorfmuller","year":"2003","journal-title":"Eur Respir J"},{"key":"key\n\t\t\t\t20170523020623_CVT105C8","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ccm.2006.11.010","article-title":"Pathology of pulmonary hypertension","volume":"28","author":"Tuder","year":"2007","journal-title":"Clin Chest Med"},{"key":"key\n\t\t\t\t20170523020623_CVT105C9","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1378\/chest.06-2243","article-title":"A nuclear factor-kappa B inhibitor pyrrolidine dithiocarbamate ameliorates pulmonary hypertension in rats","volume":"132","author":"Mitani","year":"2007","journal-title":"Chest"},{"key":"key\n\t\t\t\t20170523020623_CVT105C10","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1172\/JCI35070","article-title":"Endothelial-derived FGF2 contributes to the progression of pulmonary hypertension in humans and rodents","volume":"119","author":"Izikki","year":"2009","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20170523020623_CVT105C11","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1160\/TH08-07-0473","article-title":"Rac-1 promotes pulmonary artery smooth muscle cell proliferation by upregulation of plasminogen activator inhibitor-1: role of NFkappaB-dependent hypoxia-inducible factor-1alpha transcription","volume":"100","author":"Diebold","year":"2008","journal-title":"Thromb Haemost"},{"key":"key\n\t\t\t\t20170523020623_CVT105C12","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1161\/ATVBAHA.110.215467","article-title":"The I{kappa}B kinase inhibitor nuclear factor-{kappa}B essential modulator-binding domain peptide for inhibition of injury-induced neointimal formation","volume":"30","author":"Grassia","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key\n\t\t\t\t20170523020623_CVT105C13","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1161\/01.ATV.0000227689.41288.5e","article-title":"Inhibition of fibroblast growth factor receptor signaling attenuates atherosclerosis in apolipoprotein E-deficient mice","volume":"26","author":"Raj","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key\n\t\t\t\t20170523020623_CVT105C14","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0008-6363(01)00274-7","article-title":"Combined effect of retinoic acid and basic FGF on PAI-1 gene expression in vascular smooth muscle cells","volume":"51","author":"Watanabe","year":"2001","journal-title":"Cardiovasc Res"},{"key":"key\n\t\t\t\t20170523020623_CVT105C15","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cardiores.2004.03.002","article-title":"Inhibition of IkappaB phosphorylation in cardiomyocytes attenuates myocardial ischemia\/reperfusion injury","volume":"63","author":"Onai","year":"2004","journal-title":"Cardiovasc Res"},{"key":"key\n\t\t\t\t20170523020623_CVT105C16","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1161\/CIRCULATIONAHA.106.634709","article-title":"Short-term administration of a cell-permeable caveolin-1 peptide prevents the development of monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy","volume":"114","author":"Jasmin","year":"2006","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170523020623_CVT105C17","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/jcp.22153","article-title":"Interleukin-1\u03b2 induces ICAM-1 expression enhancing leukocyte adhesion in human rheumatoid arthritis synovial fibroblasts: Involvement of ERK, JNK, AP-1, and NF-\u03baB","volume":"224","author":"Yang","year":"2010","journal-title":"J Cell Physiol"},{"key":"key\n\t\t\t\t20170523020623_CVT105C18","doi-asserted-by":"crossref","first-page":"5634","DOI":"10.1073\/pnas.0401060101","article-title":"Canonical pathway of nuclear factor kappa B activation selectively regulates proinflammatory and prothrombotic responses in human atherosclerosis","volume":"101","author":"Monaco","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20170523020623_CVT105C19","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1093\/cvr\/cvp069","article-title":"Functional coupling expression of COX-2 and cPLA2 induced by ATP in rat vascular smooth muscle cells: role of ERK1\/2, p38 MAPK, and NF-kappaB","volume":"82","author":"Lin","year":"2009","journal-title":"Cardiovasc Res"},{"key":"key\n\t\t\t\t20170523020623_CVT105C20","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1161\/01.RES.84.10.1223","article-title":"Regression of hypertrophied rat pulmonary arteries in organ culture is associated with suppression of proteolytic activity, inhibition of tenascin-C, and smooth muscle cell apoptosis","volume":"84","author":"Cowan","year":"1999","journal-title":"Circ Res"},{"key":"key\n\t\t\t\t20170523020623_CVT105C21","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.mvr.2004.06.001","article-title":"Cellular and molecular mechanisms of pulmonary vascular remodeling: role in the development of pulmonary hypertension","volume":"68","author":"Mandegar","year":"2004","journal-title":"Microvasc Res"},{"key":"key\n\t\t\t\t20170523020623_CVT105C22","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1378\/chest.126.4.1255","article-title":"Elevated basic fibroblast growth factor levels in patients with pulmonary arterial hypertension","volume":"126","author":"Benisty","year":"2004","journal-title":"Chest"},{"key":"key\n\t\t\t\t20170523020623_CVT105C23","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1165\/rcmb.2010-0317OC","article-title":"Autocrine fibroblast growth factor-2 signaling contributes to altered endothelial phenotype in pulmonary hypertension","volume":"45","author":"Tu","year":"2011","journal-title":"Am J Respir Cell Mol Biol"},{"key":"key\n\t\t\t\t20170523020623_CVT105C24","doi-asserted-by":"crossref","first-page":"H175","DOI":"10.1152\/ajpheart.00987.2001","article-title":"Interleukin-11 attenuates human vascular smooth muscle cell proliferation","volume":"283","author":"Zimmerman","year":"2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"key\n\t\t\t\t20170523020623_CVT105C25","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1006\/jsre.1997.5114","article-title":"The regulation of p42\/p44 mitogen-activated protein kinases in the injured rat carotid artery","volume":"70","author":"Lille","year":"1997","journal-title":"J Surg Res"},{"key":"key\n\t\t\t\t20170523020623_CVT105C26","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/jcb.20058","article-title":"Inhibition of apoptosis and caspase-3 in vascular smooth muscle cells by plasminogen activator inhibitor type-1","volume":"92","author":"Chen","year":"2004","journal-title":"J Cell Biochem"},{"key":"key\n\t\t\t\t20170523020623_CVT105C27","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1016\/j.biocel.2008.01.028","article-title":"Plasminogen activator inhibitor type 1 inhibits smooth muscle cell proliferation in pulmonary arterial hypertension","volume":"40","author":"Kouri","year":"2008","journal-title":"Int J Biochem Cell Biol"},{"key":"key\n\t\t\t\t20170523020623_CVT105C28","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1164\/rccm.200506-947OC","article-title":"A novel IkappaB kinase-beta inhibitor ameliorates bleomycin-induced pulmonary fibrosis in mice","volume":"173","author":"Inayama","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"key\n\t\t\t\t20170523020623_CVT105C29","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ejphar.2010.04.006","article-title":"NF-kappaB signaling mediates vascular smooth muscle endothelin type B receptor expression in resistance arteries","volume":"637","author":"Zheng","year":"2010","journal-title":"Eur J Pharmacol"},{"key":"key\n\t\t\t\t20170523020623_CVT105C30","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0012-3692(15)51873-4","article-title":"Thrombotic arteriopathy and anticoagulation in pulmonary hypertension","volume":"130","author":"Johnson","year":"2006","journal-title":"Chest"},{"key":"key\n\t\t\t\t20170523020623_CVT105C31","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1006\/taap.1993.1137","article-title":"Fibrinolytic activity in blood and lungs of rats treated with monocrotaline pyrrole","volume":"121","author":"Schultze","year":"1993","journal-title":"Toxicol Appl Pharmacol"},{"key":"key\n\t\t\t\t20170523020623_CVT105C32","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1160\/TH08-08-0524","article-title":"The \u2018PAI-1 paradox\u2019 in vascular remodeling","volume":"100","author":"Diebold","year":"2008","journal-title":"Thromb Haemost"},{"key":"key\n\t\t\t\t20170523020623_CVT105C33","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1093\/cvr\/cvn035","article-title":"MCP-1 induces cardioprotection against ischaemia\/reperfusion injury: role of reactive oxygen species","volume":"78","author":"Morimoto","year":"2008","journal-title":"Cardiovasc Res"},{"key":"key\n\t\t\t\t20170523020623_CVT105C34","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1164\/rccm.200610-1559OC","article-title":"Role of endothelium-derived CC chemokine ligand 2 in idiopathic pulmonary arterial hypertension","volume":"176","author":"Sanchez","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"key\n\t\t\t\t20170523020623_CVT105C35","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1755-5922.2009.00103.x","article-title":"Atorvastatin decreases C-reactive protein-induced inflammatory response in pulmonary artery smooth muscle cells by inhibiting nuclear factor-kappaB pathway","volume":"28","author":"Li","year":"2010","journal-title":"Cardiovasc Ther"},{"key":"key\n\t\t\t\t20170523020623_CVT105C36","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s11373-005-1703-2","article-title":"Reactive oxygen species and ERK 1\/2 mediate monocyte chemotactic protein-1-stimulated smooth muscle cell migration","volume":"12","author":"Lo","year":"2005","journal-title":"J Biomed Sci"}],"container-title":["Cardiovascular Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cardiovascres\/article-pdf\/99\/1\/35\/17394603\/cvt105.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,13]],"date-time":"2019-07-13T08:11:26Z","timestamp":1563005486000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article-lookup\/doi\/10.1093\/cvr\/cvt105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,30]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2013,4,30]]},"published-print":{"date-parts":[[2013,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/cvr\/cvt105","relation":{},"ISSN":["1755-3245","0008-6363"],"issn-type":[{"value":"1755-3245","type":"electronic"},{"value":"0008-6363","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4,30]]}}}